Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -870 | -1,890 | -1,470 | -890 | -120 |
| Depreciation Amortization | 420 | 1,410 | 1,060 | 710 | 5 |
| Other Working Capital | 2,390 | 1,660 | 460 | 290 | 40 |
| Other Operating Activity | 0 | 130 | -150 | -250 | -55 |
| Operating Cash Flow | $1,940 | $1,310 | $-100 | $-140 | $-130 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150 | -250 | 20 | 0 | 0 |
| Other Investing Activity | 0 | -110 | 160 | 250 | 50 |
| Investing Cash Flow | $-150 | $-360 | $180 | $250 | $50 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 50 | 50 | 50 | 50 |
| Financing Cash Flow | $0 | $50 | $50 | $50 | $50 |
| Exchange Rate Effect | 220 | 0 | 0 | 0 | 0 |
| Beginning Cash Position | 1,020 | 20 | 20 | 20 | 20 |
| End Cash Position | 3,030 | 1,020 | 150 | 190 | 4 |
| Net Cash Flow | $2,010 | $1,000 | $130 | $170 | $-10 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,940 | 1,310 | -100 | -140 | -130 |
| Free Cash Flow | 1,940 | 1,310 | -100 | -140 | -130 |